SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sanofi - SNYNewsfile Corp • 08/13/22
NIHR and Sanofi Announce First Patient Enrolled in Large European Clinical Study to Investigate Protection Against RSV, the Leading Cause of Infant Hospitalisation WorldwideBusiness Wire • 08/12/22
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial LoomsInvestors Business Daily • 08/11/22
Press Release: Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in ChinaGlobeNewsWire • 08/04/22
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in ChinaPRNewsWire • 08/04/22
Sanofi appoints new Heads of U.S. General Medicines, and North America Vaccines and Consumer HealthcarePRNewsWire • 08/03/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNYPRNewsWire • 08/01/22
Sanofi SA (SNY) CEO Paul Hudson on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/28/22
Sanofi partners with Howard University in an unprecedented pharmacy fellowship programPRNewsWire • 07/26/22